Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants aged 3 to 12 years irrespective of the gender Clinically diagnosed cases of ADHD Participants willing to give assent or consent by the legal guardian Participants with secondary comorbid conditions due to ADHD will be included
Exclusion criteria
Exclusion criteria: Participants who are under allopathic treatment either for ADHD or other disease Participants suffering from severe systemic illness or any immuno-compromised condition severe psychiatric illness substance abuse and endocrine disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine which among the predefined remedies are more effective and better indicated for management of ADHDTimepoint: Enrollment of cases 6 months Study period and follow up- 6 months. Data analysis- 2 months Report formation 2 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the changes in ADHD symptom severity using the Conners Parent Rating Scale Revised (CPRS-R). Timepoint: baseline 12 weeks 24 weeks | — |
Countries
India
Contacts
Bakson homoeopathic medical college and hospital